Boston Scientific Corp (NYSE:BSX)
| 39.20 BATS BZX Real-Time Price As of 3:41pm ET |  -0.40 / -1.01%Today’s Change | 33.42 Today|||52-Week Range 46.29 | +9.04% Year-to-Date |
Latest BSX News | Press Releases
| Here's Why You Should Retain Boston Scientific (BSX) for Now Dec 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 39.60 |
| Today’s open | 39.88 |
| Day’s range | 38.98 - 40.08 |
| Volume | 4,654,757 |
| Average volume (3 months) | 6,992,629 |
| Market cap | $55.0B |
Data as of 3:41pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | -102.40% |
| Earnings growth (this year) | +68.18% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -7.66% |
| P/E ratio | 51.0 |
| Price/Sales | 5.14 |
| Price/Book | 3.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DXCMDexcom Inc | -42.38 | -7.56% |
| BDXBecton Dickinson and... | +0.85 | +0.35% |
| BAXBaxter International... | +1.35 | +1.77% |
| WSTWest Pharmaceutical ... | -4.73 | -1.08% |
Data as of 3:41pm ET, 12/03/2021
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $9.9B |
| Annual profit (last year) | -$82.0M |
| Net profit margin | -0.83% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
